ICU Medical Inc
ICUI: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$686.00 | Bghvh | Xzrthhxr |
ICU Medical Earnings: Steady Progress Toward Quality Remediation and Smiths Integration
No-moat ICU Medical’s first-quarter results came slightly below our expectations. Nevertheless, we are maintaining our $161 fair value estimate, as we see steady progress with the company’s quality remediation and integration initiatives. We think the company is on track to fully integrate with Smiths by the end of 2025, which should bring meaningful margin improvement in the long term.